“Increasing Adoption of Point-Of-Care Diagnostics”
- One prominent trend in the global womens health diagnostics market is the increasing adoption of point-of-care diagnostics
- This trend is driven by the rising need for rapid, accessible, and accurate diagnostic solutions, especially in remote or resource-limited settings, and the growing demand for immediate clinical decision-making in women’s health issues such as pregnancy, STDs, and infectious diseases
- For instance, Abbott offers the ID NOW platform, a rapid molecular point-of-care test used for detecting infectious diseases, while QuidelOrtho provides point-of-care solutions such as the Sofia platform for pregnancy and infectious disease testing
- The convenience, speed, and reduced need for centralized lab infrastructure are making point-of-care diagnostics more appealing across both developed and emerging healthcare systems
- As healthcare models shift toward decentralized and patient-centered care, this trend is expected to significantly support market expansion and innovation in women’s health diagnostics
